Cheryl Gault, Director at Rapport Therapeutics, Inc. (RAPP), bought 3,680 shares at $27.07 ($100K) on 2026-10-22, disclosed to the SEC on 2026-10-22.
Director Cheryl Gault purchased $99,636 worth of shares at $27.07, marking the largest insider purchase in the company's history. This significant buy comes as the stock has crashed over 36% over the last month, potentially signaling a contrarian bet on a bottom.
RAPP is trading at $26.38, down 10.44% over the last 5 days and 36.45% over the last 30 days. The stock is currently 50.17% below its 52-week high of $52.93 and 11.05% above its 52-week low of $23.75.
Insider purchased the largest amount in company history; track this momentum.
Short interest is elevated at 10.54% of the float, indicating significant bearish sentiment that could pressure the stock further.
Something here stands out, but not much.
| Filing → |
| RAPP | SELL | 2026-10-23 | $64K | — | Filing → |
| RAPP | BUY | 2026-10-22 | $249K | — | Filing → |
| RAPP | BUY | 2026-10-22 | $974K | — | Filing → |